Pfizer, Merck KGaA's Bavencio hits NICE roadblock in bladder cancer coverage

Retrieved on: 2021-05-07 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

Pfizer, Merck KGaA's Bavencio hits NICE roadblock in bladder cancer coverage. View article details on hiswai:

Excerpt

Pfizer and Merck KGaA's Bavencio is the only PD-1/L1 drug allowed to treat bladder cancer patients who've responded to one round of chemo. But ...

Article found on: www.fiercepharma.com